THE INTRADAY

EW ยท Company KPIs

Edwards Lifesciences (EW) KPIs

TAVR sales growth, constant currency / underlying (quarter, YoY), TMTT sales growth, constant currency / underlying (quarter, YoY). As reported in SEC filings, with the source document for each figure.

TAVR sales growth, constant currency / underlying (quarter, YoY)

8.8% for the period ended Sep 30, 2026

Dec 31, 2024: 5.3%Mar 31, 2025: 5.4%Jun 30, 2025: 7.8%Sep 30, 2025: 10.6%Dec 31, 2025: 10.6%Mar 31, 2026: 11%Jun 30, 2026: 10.5%Sep 30, 2026: 8.8%Dec 31, 2024Sep 30, 2026

The documents read for this page do not quote a definition of this measure.

TMTT sales growth, constant currency / underlying (quarter, YoY)

45.9% for the period ended Sep 30, 2026

Dec 31, 2024: 85%Mar 31, 2025: 61.4%Jun 30, 2025: 57.1%Sep 30, 2025: 53.2%Dec 31, 2025: 44.1%Mar 31, 2026: 42.8%Jun 30, 2026: 45.2%Sep 30, 2026: 45.9%Dec 31, 2024Sep 30, 2026

The documents read for this page do not quote a definition of this measure.

Reading notes

Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked โ‰ˆ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.

This page shows the latest 8 quarters of each quarterly metric and the latest 5 fiscal years of each annual one.